Inicio › Adenocarcinoma de esófago › Illinois

Ensayos clínicos de Adenocarcinoma de esófago en Illinois

11 estudios sobre Adenocarcinoma de esófago buscan participantes en Illinois.

Ciudades en Illinois

Texto oficial del estudio (inglés)

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
y 37 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
y 54 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT05677490

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Orchard Healthcare Research Inc.- Skokie, Skokie

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06324357

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Local Institution - 0379, Chicago

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07221149

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Illinois Cancer Specialists, Arlington Heights
Illinois CancerCare - Bloomington, Bloomington
Illinois Cancer Specialists, Chicago
y 7 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07392892

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

City of Hope Cancer Center-Chicago, Zion

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07277413

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Northwestern Memorial Hospital, Chicago

Reclutando

Edades de 18 a 89 · Todos los sexos · Actualizado el 11 sept 2026 · NCT05753748

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, Chicago
Research Site, Niles
Research Site, Zion

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07431281

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Orchard Healthcare Research Inc, Skokie

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT06330064

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ingalls Family Care Center, Calumet City
UChicago Medicine - River East, Chicago
The University Of Chicago, Chicago
y 13 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 jul 2026 · NCT04389632

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

Northwestern University, Chicago

Reclutando

Edades de 18 a 89 · Todos los sexos · Actualizado el 1 jul 2026 · NCT05530343

De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.